President Donald Trump suggested Tuesday his administration intends to impose a 200% tariff rate on pharmaceutical imports ...

CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of tariffs this year.

Australia is evaluating the impact of potential US tariffs of 200% on pharmaceutical imports, Treasurer Jim Chalmers said, while reiterating that his nation’s subsidies for certain drugs are not up ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

Johnson & Johnson shares jumped to their highest price in more than three months as the US-based healthcare group shrugged ...

President-elect Trump’s plan to enact heavy tariffs on certain imports could affect the prices and availability of pharmaceutical drugs in the U.S. Trump has floated 25 percent tariffs on ...

While the bilateral trade negotiations are in the final stages of discussion between India and the US, the tariffs announced ...

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

The Trump Administration has implemented or proposed a broad range of tariffs, including on pharmaceuticals. Careful vulnerability assessments should be conducted so that policymakers can identify ...

Trump suggested that those levies would not go into effect immediately, saying he will “give people about a year, year and a ...

In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs on the pharmaceutical industry, highlighting that tariffs will initially ...